Skip to main content
BOFIK
    • Gene Editing
    • Epigenetic Reprogramming
    • Senolytics
    • Mitochondria & Metabolism
    • Regenerative Medicine
    • Drug Delivery
    • AI & Computational Biology
    • Clinical Trials
    • Biotech Business
    • Longevity Lifestyle
  • Latest
  • About
Subscribe
Menu
  • Home
  • Latest
  • Topics
  • Gene Editing
  • Epigenetic Reprogramming
  • Senolytics
  • Mitochondria & Metabolism
  • Regenerative Medicine
  • Drug Delivery
  • AI & Computational Biology
  • Clinical Trials
  • Biotech Business
  • Longevity Lifestyle
  • About
Home / Latest / 2022 / June

June 2022

1 articles

June 13, 2022
NAD+ Precursor NMN Improves Muscle Function in Clinical Trial
Mitochondria & Metabolism

NAD+ Precursor NMN Improves Muscle Function in Clinical Trial

The first rigorous human trial of NMN supplementation shows meaningful benefits for age-related muscle decline.

Dr. Anna Kowalski Dr. Anna Kowalski 6 min read

Archive

  • 2026
    • January 7
  • 2024
    • September 1
    • May 1
    • March 1
  • 2023
    • December 1
    • November 1
    • October 1
    • September 1
    • August 1
    • July 1
    • June 1
    • April 1
    • March 1
    • January 1
  • 2022
    • June 1
    • April 1
    • February 1
    • January 2
  • 2019
    • January 1
  • 2018
    • July 1

Newsletter

Get the latest bioengineering news in your inbox.

Stay Ahead of the Curve

Get the latest bioengineering and longevity news delivered to your inbox. No spam, unsubscribe anytime.

BOFIK

The Future of Human Longevity

Topics

  • Gene Editing
  • Epigenetic Reprogramming
  • Senolytics
  • Mitochondria & Metabolism
  • Regenerative Medicine
  • Drug Delivery

Company

  • About Us
  • Editorial Team
  • Contact
  • RSS Feed

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy

© 2026 BOFIK. All rights reserved.